Inicio/Acciones/ENTX

ENTX

USD

Entera Bio Ltd. Ordinary Shares

$2.100-0.090 (-4.110%)

Precio en Tiempo Real

Healthcare

Biotecnología

Israel

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$2.190

Máximo

$2.280

Mínimo

$2.040

Volumen

0.01M

Fundamentos de la Empresa

Capitalización de Mercado

95.4M

Industria

Biotecnología

País

Israel

Estadísticas de Negociación

Volumen Promedio

0.04M

Bolsa

NCM

Moneda

USD

Rango de 52 Semanas

Mínimo $1.41Actual $2.100Máximo $2.79

Noticias Relacionadas

15 abr 2025 · 12:30

GlobeNewswire

Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO

JERUSALEM, April 15, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced highlights from Dr. Rachel B Wagman's oral

Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO

28 mar 2025 · 20:05

GlobeNewswire

Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates

JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key business